- According to the latest disclosed agreement terms, if the merger transaction is terminated under certain circumstances, Thermon Group Holdings (hereinafter referred to as Thermon) will be required to pay CECO Environmental a termination fee of up to $74.7 million.
- NRG Energy announced that it will maintain its adjusted EPS growth rate target at above 14% and extend the achievement period of this target to 2030.
- According to the latest data from LSEG Ibes, fintech giant Fidelity National Information Services Inc has released its financial outlook for fiscal year 2026.
- Rekor Systems Inc announced that its ongoing business integration initiative is expected to significantly reduce the company's cash outflow, thereby effectively strengthening its overall financial health.
- StarkWare CEO proposes a five-step action plan, calling on the crypto industry to address the potential threat of quantum computing
- Swap markets stabilize, Treasury yield curve flattens
- JPMorgan US Treasury client survey shows highest neutral proportion since December 2024
- CryptoQuant warns of extreme USDT liquidity pressure, bitcoin price may be approaching the bottom
- Gold market analysis for February 24 - key intra-day price entry levels for active traders
- Pi Network marks 1-year open mainnet milestone with Pi Coin at all-time lows
- Enviri's (NYSE:NVRI) Q4 CY2025 Sales Top Estimates
- Bitcoin teeters near $63,000 as pippin's rally shows froth remains
- Bitcoin Price Prediction: ETF Exodus Pushes BTC Toward 200-Week MA At $58,500
- Why XRP is Down Today-According to ChatGPT, Claude, and Grok
- Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
- DXY: ING expects the range-bound trend to persist
- Pi Coin Sees Rare Buying as Network Migration Jumps 60% — Bottom Finally In?
- Acurast turns 225,000 smartphones into a secure AI network on Base
- Outflows Accelerate as Crypto Investment Products Face Sluggish Demand
- Goldman Sachs Team: Heavy Asset Stocks Outperform Amid Concerns Over AI Disruption
- U.S. Stocks Move｜Novo Nordisk drops 3% pre-market after cutting semaglutide prices in the U.S. by 50%
- Sotera Health Company's (NASDAQ:SHC) Q4 CY2025: Beats On Revenue
- Michael Saylor compares bitcoin's 45% pullback to Apple's low point in 2013
- Glassnode: Over 400,000 bitcoins have been accumulated in the $60,000 to $70,000 range, forming a dense cost support zone.
- US Stock Market Pre-market Highlights | Trump’s 10% Global Tariff Takes Effect! AMD and Meta Announce Major Strategic Partnership
- Pi Network marks 1-year open mainnet milestone with Pi Coin at all-time lows
- Wintermute Flags Bitcoin $64K–$67K Range
- DigitalOcean (NYSE:DOCN) Beats Q4 CY2025 Sales Expectations, Growth To Accelerate Next Year
- Bowhead Specialty (NYSE:BOW) Surprises With Q4 CY2025 Sales
- Stardust Power Joins Cornerstone Consortium to Support U.S. Critical Minerals and Industrial Base Resilience
- Arq Schedules Fourth Quarter & Full-Year 2025 Earnings Conference Call
- TopBuild to Acquire Johnson Roofing
- Giant Containers Retained to Design, Deliver New Modular Structures for World-Leading EV Company
- Rekor Systems Announces Strategic On-Shoring of Overseas Engineering Operations to Advance Cost Discipline and Operational Efficiency
- Apogee Therapeutics to Participate in Upcoming March Conferences
- Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution
- Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
- Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples
- Stablecoins reinvent the intermediary and build bottlenecks, once again
- Yen Drops Amid Dual Setbacks
- Jake Claver to XRP Holders: Your Hardware Wallet Does Nothing When IRS Shows Up
- Pundit Identifies “Extremely Great Indicator” to Predict XRP Price Trends
- Decred defies Bitcoin slump as shrinking supply lifts DCR price
- Why Is BWX Technologies Stock Soaring Tuesday?
- PTLE Announces 1-for-80 Share Consolidation
- WLFI Price In Trouble as Whale Activity Spikes: Is More Downside Ahead?
- Bitcoin and Ethereum ETFs Struggle While XRP ETFs Stay Positive During Market Crash
- Keurig Dr Pepper Inc recently announced its long-term financial targets, projecting that by 2026, the company’s adjusted diluted earnings per share (EPS) will achieve low double-digit percentage growth on a constant currency basis.
- Biopharmaceutical company Fulcrum Therapeutics recently disclosed that by the end of 2025, its total holdings of cash, cash equivalents, and marketable securities will reach $352.3 million.
- Enviri Corporation recently disclosed that an audit revealed a historical accounting error related to a UK pension plan, which had been fully frozen decades ago.
- Nokia Partners With AWS To Transform Network Slicing For Telecom Providers
- Data released by Iovance Biotherapeutics, Inc. shows that its core therapy Lifileucel demonstrates a favorable safety profile.
- Avanos Medical Inc announces the expansion of its transformation plan, expecting these initiatives to deliver incremental annualized savings of $15 million to $20 million by the end of 2026.
- Biopharmaceutical company Fulcrum Therapeutics recently disclosed that by the end of 2025, its total holdings of cash, cash equivalents, and marketable securities will reach $352.3 million.
- First Watch Restaurant Group recently announced its capital expenditure plan for fiscal year 2026, with a total investment expected to reach $150 millions to $160 millions.
- Iovance Biotherapeutics recently announced plans to launch a single-arm registration clinical trial in the second quarter of 2026.
- According to the latest guidance median forecast, the 2026 adjusted EBITDA of Enviri Corporation's two core businesses—Harsco Environmental and Harsco Rail—is expected to see a slight decline compared to 2025.
- Iovance Biotherapeutics recently announced that its tumor-infiltrating lymphocyte (TIL) therapy for soft tissue sarcoma has achieved positive results in its first clinical trial.
- Enviri Corporation recently released a forecast stating that the cumulative net impact of the company’s pension obligations is expected to reach approximately $18 million by the end of 2025.
- Keurig Dr Pepper (NASDAQ:KDP) Exceeds Q4 CY2025 Expectations
- Solana Signals Clash as $68 Support Holds While RWA Hits $1.68B
- Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE
- Galaxy Digital Spotlights Stablecoins and Smart Contracts Reshaping Blockchain Lending
- Saxo Bank: Cryptocurrencies fall as risk-off sentiment rises
- Gilat Receives $39 Million in Orders for Sidewinder ESA Terminals
- Oil: Escalation risks and fair value gap – Commerzbank
- US Stocks Move｜AMD Surges Over 13% Pre-market After Reaching Multi-Billion Dollar AI Equipment Procurement Deal with Meta
- AI agents can’t run wild without on-chain identity | Opinion
- Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
- XRP Price Tests Crucial Floor, Bearish Bias Strengthens Further
- Crypto markets bleed as bitcoin hovers above liquidation zone
- Pundit: February 29 Will Be Huge for XRP. Just Got Some Massive Inside Info
- Pundit: February 29 Will Be Huge for XRP. Just Got Some Massive Inside Info
- Ocular Therapeutix to Participate in March Investor Conferences
- Ocular Therapeutix to Participate in March Investor Conferences
- Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas
- Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
- Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
- Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
- Shoals Technologies Group, Inc. Reports Financial Results for Fourth Quarter 2025
- Aquestive Therapeutics to Report Fourth Quarter 2025 Financial Results and Recent Business Highlights on March 4 and Host Conference Call on March 5 at 8:00 a.m. ET
- Axsome Therapeutics Initiates CLARITY Phase 3 Trial of Solriamfetol in Adults with Major Depressive Disorder with Excessive Daytime Sleepiness Symptoms
- Avalo Therapeutics to Participate in Upcoming Investor Conferences
- Dianthus Therapeutics to Participate in The TD Cowen 46th Annual Health Care Conference
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
- Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
- Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026
- EyePoint Announces Participation at Upcoming Investor Conferences
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025
- iBio to Participate in Upcoming Investor Conferences
- Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
- Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
- Uber's Bet On SpotHero Could Set New Standard For Urban Mobility
- Option Care Health Announces Financial Results for Fourth Quarter and Full Year 2025
- Mobilicom to Participate at Enforce Tac 2026, Germany's Prominent Trade Fair for Security and Defense
- Shoals Technologies Group and ON.energy to Deploy Critical-Power Systems for Leading AI Data-Center Operator
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Autolus Therapeutics to Participate in Upcoming Investor Conferences
- Cipher Digital Provides Fourth Quarter and Full Year 2025 Business Update
- Kymera Therapeutics to Participate in Upcoming March Investor Conferences
